首页> 外文OA文献 >The study of albumin release from silica/albumin as a potential drug delivery carrier
【2h】

The study of albumin release from silica/albumin as a potential drug delivery carrier

机译:二氧化硅/白蛋白作为潜在药物传递载体释放白蛋白的研究

摘要

The drug-delivery field has been an attractive as well as challenging area for research. With the emerging of new formulated drugs and pharmaceutical compounds, development of good drug-delivery system (DDS) is crucially required. This study aims to utilize albumin as the drug template in silica/albumin/drug (S/A/D) system. Prior to designing this system, the interaction between silica and albumin was investigated. It is hypothesized that high interaction between silica and albumin may result in slower drug release over time, which is preferred for a good DDS. Silica and albumin (S/A) materials were prepared by using fumed silica and tetraethyl orthosilicate (TEOS) as the silica precursors. Three different S/A samples were prepared; fumed silica with albumin (FS/A), fumed silica with pre-treated albumin by sodium borohydrate (FS/A-N), and silica sol (TEOS) with albumin (SS/A). In-vitro release of albumin in phosphate buffer solution (pH 7) was carried out to examine the interaction between albumin and silica. The concentration of albumin was detected at 280 nm by UV-visible spectrophotometer. All samples were characterized by diffuse reflectance-UV-visible spectrophotometer (DR-UV), Fourier transform infrared spectrophotometer (FTIR) dan thermogravimetric-differential thermal analysis (TG-DTA). DR-UV results show that SS/A exhibited the lowest absorption intensity at 280 nm, which indicates better interaction between silica and albumin. This result was supported by the presence of Si-O stretching band of silanol at 952 cm-1 from the FTIR spectrum. Release study of albumin demonstrated that the release of albumin from SS/A was slowest compared to those of FS/A and FS/A-N.
机译:药物输送领域一直是一个有吸引力且充满挑战的研究领域。随着新配方药物和药物化合物的出现,迫切需要开发良好的药物输送系统(DDS)。这项研究旨在利用白蛋白作为二氧化硅/白蛋白/药物(S / A / D)系统中的药物模板。在设计该系统之前,研究了二氧化硅和白蛋白之间的相互作用。假设二氧化硅和白蛋白之间的高相互作用可能导致随着时间的流逝药物释放缓慢,这对于良好的DDS而言是优选的。二氧化硅和白蛋白(S / A)材料是通过气相法二氧化硅和原硅酸四乙酯(TEOS)作为二氧化硅前体制备的。制备了三个不同的S / A样品。含白蛋白的气相二氧化硅(FS / A),含硼酸钠的预处理白蛋白的气相二氧化硅(FS / A-N)和含白蛋白的二氧化硅溶胶(TEOS)。进行白蛋白在磷酸盐缓冲溶液(pH 7)中的体外释放以检查白蛋白与二氧化硅之间的相互作用。用紫外可见分光光度计在280nm处检测白蛋白浓度。所有样品均通过漫反射紫外可见分光光度计(DR-UV),傅立叶变换红外分光光度计(FTIR)和热重-差热分析(​​TG-DTA)进行表征。 DR-UV结果表明,SS / A在280 nm处表现出最低的吸收强度,这表明二氧​​化硅和白蛋白之间的相互作用更好。距离FTIR光谱在952 cm-1处存在硅烷醇的Si-O拉伸带,支持了这一结果。白蛋白的释放研究表明,与FS / A和FS / A-N相比,SS / A的白蛋白释放最慢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号